<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-13T02:44:52Z</responseDate>
  <request identifier="oai:figshare.com:article/34026925" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34026925</identifier>
        <datestamp>2026-09-29T17:38:44Z</datestamp>
        <setSpec>category_4</setSpec>
        <setSpec>category_7</setSpec>
        <setSpec>category_8</setSpec>
        <setSpec>category_12</setSpec>
        <setSpec>category_46</setSpec>
        <setSpec>category_64</setSpec>
        <setSpec>category_132</setSpec>
        <setSpec>portal_5</setSpec>
        <setSpec>item_type_1</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>&lt;p&gt;Pools of &lt;i&gt;Francisella&lt;/i&gt; MHC-II peptides elicit time-dependent, specific and CD4&lt;sup&gt;+&lt;/sup&gt; T cell-mediated IFN-γ response in immune splenocytes.&lt;/p&gt;</dc:title>
          <dc:creator>Pavlina Laskova (25138447)</dc:creator>
          <dc:creator>Stanislava Porkertova (25138450)</dc:creator>
          <dc:creator>Ondrej Ballek (11568544)</dc:creator>
          <dc:creator>Lucie Balonova (1392496)</dc:creator>
          <dc:creator>Jana Pavloskova (25138453)</dc:creator>
          <dc:creator>Ales Neuwirth (13913055)</dc:creator>
          <dc:creator>Ivona Pavkova (2339947)</dc:creator>
          <dc:creator>Ivo Fabrik (1849519)</dc:creator>
          <dc:creator>Pavol Lukac (25138456)</dc:creator>
          <dc:creator>Luca Vannucci (14358999)</dc:creator>
          <dc:creator>Dominik Filipp (1849615)</dc:creator>
          <dc:creator>Jiri Stulik (151536)</dc:creator>
          <dc:creator>Marek Link (151527)</dc:creator>
          <dc:subject>Biochemistry</dc:subject>
          <dc:subject>Medicine</dc:subject>
          <dc:subject>Microbiology</dc:subject>
          <dc:subject>Cell Biology</dc:subject>
          <dc:subject>Immunology</dc:subject>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>Infectious Diseases</dc:subject>
          <dc:subject>sup &gt;+&lt;/ sup</dc:subject>
          <dc:subject>severe pneumonic form</dc:subject>
          <dc:subject>induced immune responses</dc:subject>
          <dc:subject>identified 57 mhc</dc:subject>
          <dc:subject>div &gt;&lt; p</dc:subject>
          <dc:subject>immunopeptidomics reveals conserved</dc:subject>
          <dc:subject>protective immune response</dc:subject>
          <dc:subject>peptide vaccine containing</dc:subject>
          <dc:subject>fully virulent strains</dc:subject>
          <dc:subject>ensure complete protection</dc:subject>
          <dc:subject>cells following immunization</dc:subject>
          <dc:subject>francisella tularensis &lt;/</dc:subject>
          <dc:subject>tularensis &lt;/</dc:subject>
          <dc:subject>using immunopeptidomics</dc:subject>
          <dc:subject>based immunopeptidomics</dc:subject>
          <dc:subject>vaccination studies</dc:subject>
          <dc:subject>subsequent screening</dc:subject>
          <dc:subject>significant role</dc:subject>
          <dc:subject>potential role</dc:subject>
          <dc:subject>least 80</dc:subject>
          <dc:subject>ii peptides</dc:subject>
          <dc:subject>human tularemia</dc:subject>
          <dc:subject>highly expressed</dc:subject>
          <dc:subject>fsc200 strain</dc:subject>
          <dc:subject>five epitopes</dc:subject>
          <dc:subject>epitopes proved</dc:subject>
          <dc:subject>early control</dc:subject>
          <dc:subject>dominant epitopes</dc:subject>
          <dc:subject>characterizing antigen</dc:subject>
          <dc:subject>cells playing</dc:subject>
          <dc:subject>cell epitopes</dc:subject>
          <dc:subject>bacterial proteome</dc:subject>
          <dc:subject>23 different</dc:subject>
          <dc:description>&lt;p&gt;C57Bl/6 mice were subcutaneously injected with 3 × 10&lt;sup&gt;4&lt;/sup&gt; CFU of &lt;i&gt;F. tularensis&lt;/i&gt; LVS and immune lymphocytes, pooled from groups of 3-4 mice, were stimulated with bacterial MHC-II peptides assembled in pools for immunogenicity assessment. The numbers of IFN-γ producing cells (SFCs) were determined at 3, 4 and 5 weeks p.i. following stimulation of (A) 5 × 10&lt;sup&gt;5&lt;/sup&gt; whole splenocytes or (B) cocultures of 3 × 10&lt;sup&gt;5&lt;/sup&gt; spleen CD4&lt;sup&gt;+&lt;/sup&gt; T cells and 3 × 10&lt;sup&gt;4&lt;/sup&gt; BMDCs with peptide pools (PP). Data of individual assayed wells per condition and mean values are shown. PPs with significant response against control without peptides (unstim) were detected with one-way ANOVA followed by Sidak’s post hoc test. The specificity with which the peptide-induced IFN-γ production depended on immune status of lymphocytes was verified by stimulation of (C) 5 × 10&lt;sup&gt;5&lt;/sup&gt; whole splenocytes (3 weeks p.i.) or (D) cocultures of 3 × 10&lt;sup&gt;5&lt;/sup&gt; spleen CD4&lt;sup&gt;+&lt;/sup&gt; T cells (4 weeks p.i.) and 3 × 10&lt;sup&gt;4&lt;/sup&gt; BMDCs with PP-3. Lymphocytes were isolated from LVS immunized (immune) or age-matched control (control) mice. Data of individual assayed wells per condition and mean values are shown. Responses were assessed for significant difference using a two-tailed t-test. (E) IFN-γ and (F) TNF-α concentrations were determined by ELISA in cell culture supernatants of 8 × 10&lt;sup&gt;5&lt;/sup&gt; LVS-immune splenocytes (3 weeks p.i.) after 48 h of PPs stimulation. Data of 3 biological replicates and mean values are shown. PPs with significant response against control without peptides were detected with one-way ANOVA followed by Dunnett’s post hoc test. PPs representing a subset of 15 peptides (Table B in &lt;a href="http://www.plospathogens.org/article/info:doi/10.1371/journal.ppat.1014597#ppat.1014597.s002" target="_blank"&gt;S1 Appendix&lt;/a&gt;) were used for all assays with 5 µM final concentration of each peptide. Ova II peptide (5 µM) was used as a negative control in some experiments. Asterisks indicate p-values (**p &lt; 0.01, ***p &lt; 0.001, ****p &lt; 0.0001, ns for p ≥ 0.05). Data are results of one experiment (A, B, C) or representative results of two biological replicates (D).&lt;/p&gt;</dc:description>
          <dc:date>2026-09-29T17:54:09Z</dc:date>
          <dc:type>Image</dc:type>
          <dc:type>Figure</dc:type>
          <dc:identifier>10.1371/journal.ppat.1014597.g003</dc:identifier>
          <dc:relation>https://figshare.com/articles/figure/_p_Pools_of_i_Francisella_i_MHC-II_peptides_elicit_time-dependent_specific_and_CD4_sup_sup_T_cell-mediated_IFN-_response_in_immune_splenocytes_p_/34026925</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
